ATE531697T1 - Neuartige imidazolinylmethyl-aryl-sulfonamide - Google Patents

Neuartige imidazolinylmethyl-aryl-sulfonamide

Info

Publication number
ATE531697T1
ATE531697T1 AT09708902T AT09708902T ATE531697T1 AT E531697 T1 ATE531697 T1 AT E531697T1 AT 09708902 T AT09708902 T AT 09708902T AT 09708902 T AT09708902 T AT 09708902T AT E531697 T1 ATE531697 T1 AT E531697T1
Authority
AT
Austria
Prior art keywords
novel
methyl aryl
aryl sulfonamides
imidazolinyl
imidazolinyl methyl
Prior art date
Application number
AT09708902T
Other languages
English (en)
Inventor
Counde O'yang
Dennis Mitsugu Yasuda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE531697T1 publication Critical patent/ATE531697T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT09708902T 2008-02-04 2009-01-26 Neuartige imidazolinylmethyl-aryl-sulfonamide ATE531697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2583608P 2008-02-04 2008-02-04
PCT/EP2009/050837 WO2009098133A1 (en) 2008-02-04 2009-01-26 Novel imidazolinylmethyl aryl sulfonamides

Publications (1)

Publication Number Publication Date
ATE531697T1 true ATE531697T1 (de) 2011-11-15

Family

ID=40456344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09708902T ATE531697T1 (de) 2008-02-04 2009-01-26 Neuartige imidazolinylmethyl-aryl-sulfonamide

Country Status (12)

Country Link
US (1) US20090197933A1 (de)
EP (1) EP2238115B1 (de)
JP (1) JP2011511023A (de)
KR (1) KR20100096266A (de)
CN (1) CN101925579A (de)
AT (1) ATE531697T1 (de)
AU (1) AU2009211503A1 (de)
BR (1) BRPI0907495A2 (de)
CA (1) CA2711724A1 (de)
IL (1) IL206763A0 (de)
MX (1) MX2010008019A (de)
WO (1) WO2009098133A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022047052A1 (en) * 2020-08-27 2022-03-03 Curasen Therapeutics, Inc. α1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
NZ535823A (en) * 2002-04-23 2007-07-27 Hoffmann La Roche Imidazolin-2-ylmethyl substituted aralkylsulfonamides

Also Published As

Publication number Publication date
EP2238115B1 (de) 2011-11-02
EP2238115A1 (de) 2010-10-13
CA2711724A1 (en) 2009-08-13
BRPI0907495A2 (pt) 2019-02-26
US20090197933A1 (en) 2009-08-06
WO2009098133A1 (en) 2009-08-13
MX2010008019A (es) 2010-08-10
AU2009211503A1 (en) 2009-08-13
JP2011511023A (ja) 2011-04-07
CN101925579A (zh) 2010-12-22
IL206763A0 (en) 2010-12-30
KR20100096266A (ko) 2010-09-01

Similar Documents

Publication Publication Date Title
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
MX390264B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
EA201001724A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
ATE517882T1 (de) Chinolinderivate
EA201390766A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
CY1119357T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν συνδετες υποδοχεων σιγμα
UA112317C2 (uk) Похідні 2-(1,2,3-триазол-2-іл)бензаміду та 3-(1,2,3-триазол-2-іл)піколінаміду як антагоністи рецептора орексину
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA200970341A1 (ru) Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
EA201390163A1 (ru) Гетеробициклические производные в качетстве ингибиторов hcv
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3
ATE552246T1 (de) Substituierte aryloxy-n- bicyclomethylacetamidverbindungen als vr1- antagonisten
EA201391524A1 (ru) Производные гликозида и их применение
EA201001566A1 (ru) Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
MA32479B1 (fr) Compoés nouveaux actifs comme antagonistes des recepteurs muscariniques
EA200901030A1 (ru) Антагонист хроменового рецептора s1p1
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
EA201290534A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов
EA201270556A1 (ru) Конденсированные тиазоло и оксазолопиримидиноны
ATE525360T1 (de) Neuartige imidazolinylmethyl-aryl-sulfonamide
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
EA201390488A1 (ru) Новые агонисты gpr 119